The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Supply Chain Strategies & Solutions Article
The CQO movement is the health care supply chain’s fitness tracker.
Supply Chain Strategies & Solutions Article
Cost per case is a valuable measure because it captures multiple data points.
Supply Chain Strategies & Solutions Article
Successful CQO initiatives must start with data that is reliable and accurate, but it takes physician leadership to make sure it is also mean